Global Pharmaceutical Player Uses the Annual Report to Address Lingering Brand Symptoms

SciClone is a research and development-oriented pharmaceutical company working to develop a treatment for Hepatitis B and C as well as certain cancers. Their most recognizable product, ZADAXIN®, is sold in over 30 countries.

Sciclone1 Sciclone2 Sciclone3

Their mixed bag of logo treatments and messages made it difficult for SciClone to appear organized, or to be taken seriously as a global pharmaceuticals player. So the first step was an identity clarification. With that in hand, FINE designed a clean and elegantly-paced annual report that provided an immediate orientation to readers on the core areas of success for SciClone, delivered in a format that dramatized the diseases the company fights with stark statistics and abstract, humanizing imagery. Along the way, an efficient delivery of the year’s message and financials.

Share This